4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 4 USDMF, 2 NDC API, 8 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

36 FDF Dossiers, 4 FDA Orange Book, 9 Europe, 4 Australia, 7 South Africa, 12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM, EXTENDED RELEASE;TRANSDERMAL - 3.9MG/24HR, GEL, METERED;TRANSDERMAL - 3%, FILM, EXTENDED RELEASE;TRANSDERMAL - 3.9MG/24HR

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 1 Actylis, 2 BASF, 1 Finar, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

3 Film Formers & Plasticizers, 3 Topical, 2 Parenteral, 2 Solubilizers, 1 Thickeners and Stabilizers, 1 Emulsifying Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 4 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 11 Finished Drug Prices

MARKET PLACE

4 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Filters

FILTER :

filter Order Code Reset all filters

2 All

01 1O0288000

02 1O0288005

filter CAS Number Reset all filters

filter Reference Standard Reset all filters

Product Main Page

01

EDQM, Council of Europe

Oxybutynin impurity A

American Pharma Summit

Not Confirmed

02

EDQM, Council of Europe

Oxybutynin hydrochloride

American Pharma Summit

Not Confirmed

Contact us
to update this info